Treating Patients With Traumatic Chondral Lesions With Autologous Bone Marrow Cells Derived Engineered Tissues - Engineered Osteochondral Tissue

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions

Traumatic Cartilage Injury

Interventions

COMBINATION_PRODUCT

eOCT implantation

eOCT is regarded as an Advanced Therapy Product (ATP).

Trial Locations (2)

RECRUITING

Queen Elizabeth Hospital, Jordon

RECRUITING

Prince of Wales Hospital, Shatin

All Listed Sponsors

lead

Chinese University of Hong Kong

OTHER